For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959

+ Details

Name:	us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

+ Details

Name:	us-gaap_EffectiveIncomeTaxRateContinuingOperations
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Sum of the carrying amounts as of the balance sheet date of all investments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.1(h))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

+ Details

Name:	us-gaap_Investments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ProductInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Product Information [Line Items]
Effective tax rate	0.00%	0.00%	(4.00%)	(2.00%)
Veritone [Member]
Product Information [Line Items]
Investment in Veritone	$ 982		$ 982
Measurement Input, Price Volatility [Member] \| Embedded Derivative [Member]
Product Information [Line Items]
Assumptions used for derivatives			32 percent
Measurement Input, Price Volatility [Member] \| Black Scholes Model [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Assumptions used for derivatives			32 percent
Measurement Input, Price Volatility [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 525 [Member]
Product Information [Line Items]
Assumptions used for derivatives			32 percent
Measurement Input, Price Volatility [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 365 [Member]
Product Information [Line Items]
Assumptions used for derivatives			51 percent
Measurement Input, Risk Free Interest Rate [Member] \| Embedded Derivative [Member]
Product Information [Line Items]
Assumptions used for derivatives			0.47 percent
Measurement Input, Risk Free Interest Rate [Member] \| Black Scholes Model [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Assumptions used for derivatives			0.47 percent
Measurement Input, Risk Free Interest Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 525 [Member]
Product Information [Line Items]
Assumptions used for derivatives			0.48 percent
Measurement Input, Risk Free Interest Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 365 [Member]
Product Information [Line Items]
Assumptions used for derivatives			0.13 percent
Measurement Input, Expected Term [Member] \| Black Scholes Model [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Assumptions used for derivatives			7.04 years
Measurement Input, Expected Term [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 525 [Member]
Product Information [Line Items]
Assumptions used for derivatives			7.12 years
Measurement Input, Expected Term [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 365 [Member]
Product Information [Line Items]
Assumptions used for derivatives			1.9 years
Measurement Input, Expected Dividend Rate [Member] \| Embedded Derivative [Member]
Product Information [Line Items]
Assumptions used for derivatives			0 percent
Measurement Input, Expected Dividend Rate [Member] \| Black Scholes Model [Member] \| Series A Warrants [Member]
Product Information [Line Items]
Assumptions used for derivatives			0 percent
Measurement Input, Expected Dividend Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 525 [Member]
Product Information [Line Items]
Assumptions used for derivatives			0 percent
Measurement Input, Expected Dividend Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 365 [Member]
Product Information [Line Items]
Assumptions used for derivatives			0 percent
Measurement Input, Discount Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 525 [Member]
Product Information [Line Items]
Assumptions used for derivatives			10 percent
Measurement Input, Discount Rate [Member] \| Monte Carlo Method [Member] \| Series B Warrants [Member] \| Warrant Price 365 [Member]
Product Information [Line Items]
Assumptions used for derivatives			10 percent
Measurement Input, Credit Spread [Member] \| Embedded Derivative [Member]
Product Information [Line Items]
Assumptions used for derivatives			21 percent
Revenue Benchmark [Member] \| One Licensee [Member]
Product Information [Line Items]
Concentration risk percentage	98.00%	52.00%	75.00%	46.00%
Revenue Benchmark [Member] \| One Licensee 2 [Member]
Product Information [Line Items]
Concentration risk percentage		21.00%	9.00%	23.00%
Revenue Benchmark [Member] \| One Licensee 3 [Member]
Product Information [Line Items]
Concentration risk percentage		12.00%	8.00%	14.00%
Revenue Benchmark [Member] \| One Licensee 4 [Member]
Product Information [Line Items]
Concentration risk percentage			4.00%
Revenue Benchmark [Member] \| Foreign Licensee [Member]
Product Information [Line Items]
Concentration risk percentage	0.10%	75.00%	5.00%	38.00%
Accounts Receivable [Member] \| One Licensee [Member]
Product Information [Line Items]
Concentration risk percentage			57.00%		70.00%
Accounts Receivable [Member] \| One Licensee 2 [Member]
Product Information [Line Items]
Concentration risk percentage			25.00%		17.00%
Accounts Receivable [Member] \| One Licensee 3 [Member]
Product Information [Line Items]
Concentration risk percentage			4.00%
Accounts Receivable [Member] \| One Licensee 4 [Member]
Product Information [Line Items]
Concentration risk percentage			3.00%